Westpac Banking Corp’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-10,600
Closed -$471K 858
2017
Q1
$471K Sell
10,600
-22
-0.2% -$946 ﹤0.01% 826
2016
Q4
$469K Sell
10,622
-57
-0.5% -$2.42K ﹤0.01% 732
2016
Q3
$428K Buy
10,679
+155
+1% +$6.58K ﹤0.01% 717
2016
Q2
$502K Buy
10,524
+3,474
+49% +$147K 0.01% 728
2016
Q1
$296K Buy
7,050
+65
+0.9% +$2.55K ﹤0.01% 762
2015
Q4
$308K Buy
6,985
+1,288
+23% +$55.9K ﹤0.01% 767
2015
Q3
$272K Buy
5,697
+2,222
+64% +$122K ﹤0.01% 745
2015
Q2
$202K Buy
+3,475
New +$187K ﹤0.01% 658

Other funds holding CNMD

Westpac Banking Corp's CNMD Position: Q2 2017 in Review

Westpac Banking Corp sold out of CONMED (CNMD) in Q2 2017, closing a stake of 10,600 shares — an estimated $471K sold.

Westpac Banking Corp first reported a position in CNMD in Q2 2015 and held it in 8 quarters. The position peaked at $502K in Q2 2016. 150 funds tracked by Wall St. Rank hold CNMD as of Q2 2017.

  • Westpac Banking Corp reported no remaining CONMED position as of Q2 2017 after selling out during the quarter.
  • Westpac Banking Corp sold 10,600 CONMED shares in Q2 2017, an estimated $471K.
  • Westpac Banking Corp first reported a position in CONMED in Q2 2015 and held it in 8 quarters.
  • Westpac Banking Corp's CONMED position peaked at $502K in Q2 2016.
  • 150 funds tracked by Wall St. Rank held CONMED as of Q2 2017.

Based on Westpac Banking Corp's 13F filing for Q2 2017, filed 9 Aug 2017.